Read Why this Symposium is So Important
4-6 pm PST
Karim Kader M.D. Ph.D., Chief Medical Officer and co-founder of Stratify Genomics, and UCSD Professor of Urology, as our keynote speaker. He will present an overview of our inherited (germline) genetics and potential impact on disease.
Franklin Gaylis MD, FACS, Chief Scientific Officer at Genesis Healthcare Partners and UCSD voluntary Professor of Urology will moderate the presentation.
Clive Essakow will speak on prostate cancer and genetic testing from a lay person’s perspective.
Sarah Abelsohn will speak on her experience as a BRCA carrier detected after the loss of her mom, Sandi Abelsohn, to breast cancer.
BREAK OUT SESSION SPEAKERS
(Registration required beforehand)
- Our Symposium is supported by generous donations from our sponsors:
Myriad is an established leader in the field of hereditary cancer genetic testing with nearly 30 years of experience and approximately 5 million patients tested. We are committed to providing patients with affordable and accurate information that they can rely upon when decisions matter most.
Invitae is a leader in advanced medical genetics. Our company was founded with a singular mission: to make genetic information affordable and accessible to everyone who can benefit from it. The Invitae team includes pioneers in genetics, medicine, technology, and genetic counseling, and is trusted by experts to provide the most comprehensive, reliable genetic screening and support available. Invitae addresses genetic questions through all stages of life and all areas of medicine. Improving the quality of healthcare by making genetic information affordable and accessible for everyone.
Sharsheret, Hebrew for chain, is the only national organization supporting Jewish women and families, of all backgrounds, facing breast and ovarian cancer—those who are diagnosed and those at high risk. They are accredited by the Better Business Bureau and have earned a 4-star rating from Charity Navigator for sound fiscal management and commitment to accountability and transparency.
JScreen is a national non-profit public health initiative dedicated to preventing Jewish genetic diseases. Headquartered in Atlanta at Emory University School of Medicine, JScreen offers at-home carrier testing for over 200 genetic diseases that could impact a couple’s future children, as well as follow up genetic counseling services. JScreen is also launching a cancer genetic testing program in October 2020.